The ARNA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARNA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ARNA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ARNA Detailed Price Forecast - CNN Money||View ARNA Detailed Summary - Google Finance|
|View ARNA Detailed Summary - Yahoo! Finance||View ARNA Stock Research & Analysis - Zacks.com|
|View ARNA Trends & Analysis - Trade-Ideas||View ARNA Major Holders - Barrons|
|View ARNA Call Transcripts - NASDAQ||View ARNA Breaking News & Analysis - Seeking Alpha|
|View ARNA Annual Report - CompanySpotlight.com||View ARNA OTC Short Report - OTCShortReport.com|
|View ARNA Fundamentals - TradeKing||View ARNA SEC Filings - Bar Chart|
|View Historical Prices for ARNA - The WSJ||View Performance/Total Return for ARNA - Morningstar|
|View the Analyst Estimates for ARNA - MarketWatch||View the Earnings History for ARNA - CNBC|
|View the ARNA Earnings - StockMarketWatch||View ARNA Buy or Sell Recommendations - MacroAxis|
|View the ARNA Bullish Patterns - American Bulls||View ARNA Short Pain Metrics - ShortPainBot.com|
|View ARNA Stock Mentions - StockTwits||View ARNA Stock Mentions - PennyStockTweets|
|View ARNA Stock Mentions - Twitter||View ARNA Investment Forum News - Investor Hub|
|View ARNA Stock Mentions - Yahoo! Message Board||View ARNA Stock Mentions - Seeking Alpha|
|View Insider Transactions for ARNA - SECform4.com||View Insider Transactions for ARNA - Insider Cow|
|View ARNA Major Holdings Summary - CNBC||View Insider Disclosure for ARNA - OTC Markets|
|View Insider Transactions for ARNA - Yahoo! Finance||View Institutional Holdings for ARNA - NASDAQ|
|View ARNA Stock Insight & Charts - FinViz.com||View ARNA Investment Charts - StockCharts.com|
|View ARNA Stock Overview & Charts - BarChart||View ARNA User Generated Charts - Trading View|
Arena Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference on February 27
Posted on Thursday February 21, 2019
SAN DIEGO, Feb. 21, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, will present a corporate update at the 8th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 27, 2019 at 9:30 AM EST. A live audio webcast of the presentation will be available under the investor relations section of Arena's website at www.arenapharm.com. Arena Pharmaceuticals is driven to deliver novel, transformational medicines with optimized pharmacology and pharmacokinetics to patients globally.
Arena Pharmaceuticals to Announce Fourth Quarter and Full-Year 2018 Financial Results and Provide Corporate Update on February 26
Posted on Wednesday February 20, 2019
SAN DIEGO , Feb. 20, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will announce its fourth quarter and full-year 2018 financial results on Tuesday, February 26, 2019 , after the close ...
Top 3 Marijuana Stocks on the NASDAQ
Posted on Friday February 15, 2019
Uplisting from an OTC market to a reputable U.S. exchange has become a banner achievement for many rising marijuana companies.
Arena Pharmaceuticals Presents Preclinical and Early Clinical Development Data for Olorinab at Crohn's & Colitis Congress
Posted on Thursday February 07, 2019
SAN DIEGO, Feb. 7, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) will present preclinical and early clinical development data from its investigative drug candidate olorinab, a peripherally restricted, highly selective, full agonist of the cannabinoid receptor type 2 (CB2) in development for the treatment of visceral pain associated with gastrointestinal diseases, at the Crohn's & Colitis Congress® in Las Vegas, NV.